drugset / Trial / NCT00062023

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

NCT00062023

RandomizedSingle-groupSingle-blindPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether sulindac, aspirin, or ursodiol is more effective in preventing colorectal cancer. PURPOSE: This randomized phase II trial is studying how well sulindac works compared to aspirin or ursodiol in preventing colorectal cancer.

Timeline

Start
2003-06
Primary completion
2005-04
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule Oral
Comparator Sulindac Small molecule Oral
Comparator Ursodeoxycholic Acid Small molecule Oral

Indications